Consultant Cardiologist Dr Jason Dungu discusses the variants of cardiac amyloidosis and the treatments available. He explores the challenges faced by black patients with heart failure who are often under-diagnosed and under-represented in the UK.
Kerendia is a nonsteroidal mineralocorticoid receptor antagonist (nsMRA) that is clinically and pharmacologically distinct from steroidal MRAs (sMRAs).1–4
Clinical exercise physiologist Shane Purcell talks through the optimal ways in which patients can incorporate exercise into their cardiac rehabilitation routine, improving outcomes and quality of life.
Dr Sharon Chadwick discusses these challenging issues and more, explaining how the end-of-life care for heart failure patients can and should be improved. She explores how palliative care doesn't necessarily mean the end of living well for patients with heart failure.
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.